|
|
| March 18, 2017: Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: SPIRE 1 and SPIRE 2: Safety and Cardiovascular Event Efficacy of Boco |
Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: SPIRE 1 and SPIRE 2: Safety and
Cardiovascular Event Efficacy of Bococizumab Among 27,000 High Risk Patients
TBD
[ Download video ] |
|
No comments have been submitted
|